Rucaparib Recruiting Phase 2 Trials for Cervical Cancers / Endometrial Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03476798Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium